The Multidisciplinary Association for Psychedelic Studies (MAPS) phase 3 studies utilize MDMA doses ranging from 0.08 to 0.18 grams per patient.

Authors

• Person: Not available Organization: Springer
  Effects of psychedelics on neurogenesis and broader neuroplasticity

Sources

• Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com Springer via serper

Referenced by nodes (1)

• MDMA concept